🧠 Watchlist Winners: Copy Legendary Investors' Portfolios in One ClickCOPY FOR FREE

Immuneering Corp (IMRX)

NASDAQ
Currency in USD
Disclaimer
2.020
+0.590(+41.26%)
Closed
After Hours
2.0200.000(0.00%)
IMRX Scorecard
Full Analysis
Holds more cash than debt on its balance sheet
Unusual trading volume
Fair Value
Day's Range
1.8402.580
52 wk Range
1.0009.000
Prev. Close
1.43
Open
2.09
Day's Range
1.84-2.58
52 wk Range
1-9
Volume
136,724,965
Average Vol. (3m)
3,965,012
1-Year Change
-73.63%
Book Value / Share
Unlock
Fair Value
Unlock
Fair Value Upside
Unlock
IMRX Scorecardpro icon
Company’s Health
pro lockUnlock
Fair Value
pro lockUnlock Price
Fair Pricepro lock
Upsidepro lock
Price Target
11.214
Upside
+455.149%
Members' Sentiments
Bearish
Bullish
ProTips
Quickly burning through cash
Show more

Immuneering Corp Company Profile

Immuneering Corporation, a clinical-stage oncology company, engages in the development of medicines for broad populations of cancer patients. Its lead product candidates include IMM-1-104, a dual-MEK inhibitor currently under Phase 1/2a clinical trial to treat patients with cancer, including pancreatic, melanoma, colorectal, and non-small cell lung cancer caused by mutations of RAS and/or RAF; and IMM-6-415 is in Investigational New Drug application to treat solid tumors. Immuneering Corporation was incorporated in 2008 and is based in Cambridge, Massachusetts.

Compare IMRX to Peers and Sector

Metrics to compare
IMRX
Peers
Sector
Relationship
P/E Ratio
−1.1x−3.8x−0.6x
PEG Ratio
−1.28−0.030.00
Price / Book
0.9x2.4x2.6x
Price / LTM Sales
-23.3x3.1x
Upside (Analyst Target)
494.1%176.3%55.7%
Fair Value Upside
Unlock0.9%6.9%Unlock

People Also Watch

0.947
BNRG
-2.07%
0.5800
AZTR
-1.71%
1.7700
XRTX
+4.12%
0.8000
BBLG
-32.77%
1.6000
TBIO
-11.60%

FAQ

What Is the Immuneering (IMRX) Stock Price Today?

The Immuneering stock price today is 2.02

What Stock Exchange Does Immuneering Trade On?

Immuneering is listed and trades on the NASDAQ stock exchange.

What Is the Stock Symbol for Immuneering?

The stock symbol for Immuneering is "IMRX."

What Is the Immuneering Market Cap?

As of today, Immuneering market cap is 59.90M.

What is Immuneering Earnings Per Share?

The Immuneering EPS is -1.91.

What Is the Next Immuneering Earnings Date?

Immuneering will release its next earnings report on Nov 07, 2024.
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2024 - Fusion Media Limited. All Rights Reserved.